HEATHER WILKS: Open Payments
NPI 1538409370 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 13 payments from 11 companies in 2025. Trend: 2023 $1,768 · 2024 $1,513 · 2025 $535
Food & beverage: $337Education: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $113 |
| Incyte Corporation | 1 | $99 |
| GENZYME CORPORATION | 1 | $37 |
| Celgene Corporation | 2 | $35 |
| Genentech USA, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
Products named: Nubeqa, DARZALEX, SARCLISA, REBLOZYL, Polivy, KISQALI, NERLYNX, KISUNLA.
Industry payments across SC — which companies pay providers there.
